MktsMarkets

TherapeuticsMD, Inc.
NASDAQ: TXMDKey statistics
TXMD News
Stories mentioning TXMD from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 724.00 | 393.00 | ||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Operating Expenses | ||||||||
| Research & Development | ||||||||
| Sales General & Admin | 1,551 | 1,081 | 1,582 | |||||
| Total Operating Expenses | 1,447 | 2,445 | 1,646 | 1,647 | 1,674 | 1,714 | 1,681 | 3,023 |
| Operating Income (Loss) | (723.00) | (1,552) | (862.00) | (695.00) | (1,281) | (1,047) | (1,134) | (2,789) |
| Interest Income | 41.00 | 29.00 | ||||||
| Interest Expense | ||||||||
| Other Expense | ||||||||
| Pretax Income | 103.00 | (580.00) | 50.00 | 545.00 | (668.00) | 83.00 | (567.00) | (1,050) |
| Tax Provision | (32.00) | |||||||
| Net Income (Loss) | 95.00 | (619.00) | 152.00 | 551.00 | (653.00) | 252.00 | (609.00) | (1,090) |
| Earnings Per Share (Basic) | 0.01 | (0.05) | 0.01 | 0.05 | (0.06) | 0.02 | (0.05) | (0.09) |
| Earnings Per Share (Diluted) | 0.01 | (0.05) | 0.01 | 0.05 | (0.06) | 0.02 | (0.05) | (0.09) |
| Weighted Average Shares Outstanding (Basic) | 12.00 | 11,569 | 11,574 | 11,574 | 12.00 | 11,532 | 11,532 | 11,532 |
| Weighted Average Shares Outstanding (Diluted) | 12.00 | 11,569 | 11,574 | 11,574 | 12.00 | 11,532 | 11,532 | 11,532 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About TXMD
TherapeuticsMD, Inc. (NASDAQ: TXMD) is a stock listed on the Nasdaq Stock Market under the ticker symbol TXMD. It last traded at $1.79 (Oct 28, 2026, 4:00 PM ET), up 0.6% on the day. That gives TherapeuticsMD a market capitalisation of $20.6M.
Over the past 52 weeks TXMD has traded between $1.11 and $2.95.
Revenue for the quarter ended Mar 31, 2026 was $724.0K; net income $95.0K. Revenue was up 84.2% from $393.0K in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $724.0K | $95.0K | 13.1% |
| Dec 31, 2025 | — | -$619.0K | — |
| Sep 30, 2025 | — | $152.0K | — |
| Jun 30, 2025 | — | $551.0K | — |
From TherapeuticsMD’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…